ANI PHARMACEUTICALS INC
Total Trades
88
Buys
4
Sells
79
Largest Trade
$1M+
Insiders
14
Institutional Funds
230
Inst. Value
$1M+
Activist Filings
20
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| CAREY STEPHEN P. | SVP & CFO | SELL | $500K+ | 7K | $75.50 | Mar 5, 2026 |
| CAREY STEPHEN P. | SVP & CFO | EXERCISE | $100K–$500K | 3K | $49.51 | Mar 5, 2026 |
| Mutz Christopher | HEAD OF RARE DISEASE | SELL | $15K–$50K | 417 | $74.00 | Mar 4, 2026 |
| Gutwerg Ori | SVP, GENERICS | SELL | $100K–$500K | 2K | $76.50 | Mar 4, 2026 |
| Walsh Patrick D | Director | SELL | $100K–$500K | 6K | $74.23 | Mar 3, 2026 |
| Mutz Christopher | HEAD OF RARE DISEASE | SELL | $100K–$500K | 5K | $78.02 | Feb 23, 2026 |
| Davis Krista | SVP | SELL | $100K–$500K | 4K | $77.74 | Feb 23, 2026 |
| Mutz Christopher | HEAD OF RARE DISEASE | SELL | $500K+ | 7K | $76.55 | Feb 17, 2026 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 500 | $76.80 | Feb 17, 2026 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 500 | $84.33 | Jan 14, 2026 |
| Davis Krista | SVP | SELL | $100K–$500K | 2K | $82.40 | Dec 19, 2025 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 400 | $82.32 | Dec 12, 2025 |
| TANNENBAUM RENEE P | Director | SELL | $100K–$500K | 2K | $81.15 | Dec 9, 2025 |
| Walsh Patrick D | Director | SELL | $500K+ | 9K | $86.88 | Nov 17, 2025 |
| Gassert Chad | SVP - CORP. DEV. &… | SELL | $1M+ | 15K | $89.06 | Nov 14, 2025 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 400 | $87.27 | Nov 14, 2025 |
| Davis Krista | SVP | SELL | $50K–$100K | 1K | $98.04 | Sep 22, 2025 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 400 | $98.42 | Sep 15, 2025 |
| Pera Antonio R | Director | SELL | $500K+ | 7K | $94.94 | Sep 4, 2025 |
| Leonard Matthew J | Director | SELL | $100K–$500K | 3K | $90.62 | Aug 26, 2025 |
| Davis Krista | SVP | SELL | $100K–$500K | 2K | $91.10 | Aug 25, 2025 |
| Shanmugam Muthusamy | HEAD OF R&D | SELL | $1M+ | 100K | $90.36 | Aug 22, 2025 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 400 | $64.88 | Jul 14, 2025 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 400 | $61.37 | Jun 16, 2025 |
| Gutwerg Ori | SVP, GENERICS | SELL | $50K–$100K | 881 | $60.07 | May 16, 2025 |
| Mutz Christopher | HEAD OF RARE DISEASE | SELL | $100K–$500K | 4K | $60.45 | May 16, 2025 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 400 | $62.20 | May 13, 2025 |
| Shanmugam Muthusamy | HEAD OF R&D | SELL | $50K–$100K | 700 | $76.83 | May 13, 2025 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 400 | $68.96 | Apr 14, 2025 |
| Davis Krista | SVP | SELL | $100K–$500K | 2K | $65.00 | Mar 20, 2025 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 400 | $63.33 | Mar 14, 2025 |
| Davis Krista | SVP | SELL | $50K–$100K | 1K | $60.20 | Feb 24, 2025 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 400 | $53.92 | Jan 13, 2025 |
| Lalwani Nikhil | PRESIDENT & CEO | SELL | $1M+ | 33K | $57.99 | Nov 27, 2024 |
| Lalwani Nikhil | PRESIDENT & CEO | EXERCISE | $500K+ | 30K | $29.00 | Nov 27, 2024 |
| Mutz Christopher | HEAD OF RARE DISEASE | SELL | $100K–$500K | 7K | $57.70 | Nov 18, 2024 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 250 | $61.36 | Nov 14, 2024 |
| Cook Meredith | SR. VP | SELL | $1K–$15K | 250 | $57.19 | Oct 15, 2024 |
| Gassert Chad | SVP - CORP. DEV. &… | SELL | $1M+ | 20K | $63.44 | Jul 3, 2024 |
| Shanmugam Muthusamy | HEAD OF R&D | SELL | $1M+ | 20K | $58.90 | Jun 24, 2024 |
| Shanmugam Muthusamy | HEAD OF R&D | SELL | $1M+ | 30K | $60.59 | Jun 20, 2024 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 250 | $63.80 | Jun 14, 2024 |
| Gutwerg Ori | SVP, GENERICS | SELL | $100K–$500K | 3K | $67.00 | Jun 6, 2024 |
| CAREY STEPHEN P. | SVP & CFO | SELL | $100K–$500K | 5K | $63.58 | Jun 6, 2024 |
| Gassert Chad | SVP - CORP. DEV. &… | SELL | $1M+ | 20K | $64.41 | Jun 4, 2024 |
| Mutz Christopher | HEAD OF RARE DISEASE | SELL | $100K–$500K | 2K | $61.61 | May 22, 2024 |
| Gassert Chad | SVP - CORP. DEV. &… | SELL | $1M+ | 20K | $66.62 | May 3, 2024 |
| Shanmugam Muthusamy | HEAD OF R&D | SELL | $1M+ | 27K | $65.10 | Apr 22, 2024 |
| Shanmugam Muthusamy | HEAD OF R&D | SELL | $1M+ | 23K | $65.91 | Apr 17, 2024 |
| Cook Meredith | SR. VP | SELL | $15K–$50K | 250 | $67.79 | Apr 15, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 230 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 727K | $1M+ | SH |
| Global Alpha Capital Management Ltd. | 590K | $1M+ | SH |
| Soleus Capital Management, L.P. | 486K | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 481K | $1M+ | SH |
| Deep Track Capital, LP | 478K | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 473K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 440K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 419K | $1M+ | SH |
| Ranger Investment Management, L.P. | 362K | $1M+ | SH |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 317K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 314K | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 299K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 252K | $1M+ | SH |
| NOMURA HOLDINGS INC | 224K | $1M+ | SH |
| KENNEDY CAPITAL MANAGEMENT LLC | 214K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 205K | $1M+ | SH |
| MIZUHO MARKETS AMERICAS LLC | 202K | $1M+ | SH |
| DEUTSCHE BANK AG\ | 202K | $1M+ | SH |
| APIS CAPITAL ADVISORS, LLC | 196K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 194K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Integrated Core Strategies (US) LLC
SC 13G/A · Nov 13, 2025
0.2%
54K shares
SC 13G/A · Oct 17, 2025
11.3%
2.5M shares
Meridian Venture Partners II GP, L.P. ("GP")
SC 13D/A · Aug 22, 2025
4.7%
1.0M shares
Integrated Core Strategies (US) LLC
SC 13G · Jun 4, 2025
5.1%
1.1M shares
SC 13G/A · Apr 10, 2025
3.8%
818K shares
Meridian Venture Partners II GP, L.P. ("GP")
SC 13D/A · Mar 14, 2025
5.4%
1.2M shares
SC 13G · Jan 21, 2025
5.2%
1.1M shares
SC 13G/A · Nov 13, 2024
0.3%
57K shares
Meridian Venture Partners II GP, L.P. (“GP”)
SC 13D/A · Mar 14, 2024
6.7%
1.4M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
6.3%
1.3M shares
SC 13G · Feb 12, 2024
5.5%
1.1M shares
SC 13G/A · Jan 23, 2024
12.4%
2.5M shares
SC 13D/A · Jan 17, 2024
4.6%
933K shares
Meridian Venture Partners II GP, L.P. (“GP”)
SC 13D/A · Dec 18, 2023
8.1%
1.6M shares
SC 13D/A · Dec 5, 2023
4.8%
983K shares
Meridian Venture Partners II GP, L.P. (“GP”)
SC 13D/A · Aug 17, 2023
9.0%
1.8M shares
SC 13G/A · Jan 26, 2023
11.4%
2.0M shares
SC 13G/A · Jan 20, 2023
11.4%
2.0M shares
Meridian Venture Partners II GP, L.P. (“GP”)
SC 13D/A · Dec 12, 2022
11.6%
2.0M shares
SC 13D · Mar 2, 2022
8.0%
1.3M shares